CD274 and cancer: Secreted TAM agonists bind to TAM receptors overexpressed by cancer cells, to promote oncogenic characteristics and tumor cell aggressiveness (proliferation, migration, cell survival, drug resistance) as well as upregulate PD-L1 expression that promotes immune-evasion.